FDA Approves Sexual Desire Drug for Postmenopausal Women

(MedPage Today) — The FDA expanded the approval of flibanserin (Addyi), a drug that treats low sexual desire in women, to now include some postmenopausal women, drugmaker Sprout Pharmaceuticals announced on Monday.
Flibanserin is a mixed 5-HT1A…

Source link : https://www.medpagetoday.com/obgyn/menopause/119031

Author :

Publish date : 2025-12-15 22:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

FDA Approves Sexual Desire Drug for Postmenopausal Women

Aspiring Neurosurgeon Died in Brown Campus Shooting

Not Everyone Gets a Mortality Benefit From Reducing Saturated Fats, Study Says

Related Posts

Air Pollution Tied to Greater ALS Risk, Worse Outcomes

Ixchiq Vaccine Pulled From U.S. Market Amid Safety Concerns

Parent-Led Intervention Started in NICU Boosted Executive Function at School Age

CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma

Study: Helping Lupus Patients With Money Issues Improves Their Health

After My Breast Cancer Diagnosis, My Practice Became a Lab for Change

Air Pollution Tied to Greater ALS Risk, Worse Outcomes

Ixchiq Vaccine Pulled From U.S. Market Amid Safety Concerns

Parent-Led Intervention Started in NICU Boosted Executive Function at School Age

CAR-T Immune Toxicity Linked to Non-Relapse Mortality Risk in Myeloma

Study: Helping Lupus Patients With Money Issues Improves Their Health

After My Breast Cancer Diagnosis, My Practice Became a Lab for Change

Medicare Paying Billions More for Medicare Advantage vs Traditional Enrollees

Coming Radiotracer Shortage; Dedicated Cardiometabolic Training; New PFA Catheter

Categories

Archives